| Dr Stephan Charles Boyd Mann, MD | |
|
490l Prospect Blvd, Frederick, MD 21701-6400 | |
| (240) 566-3001 | |
| (240) 566-3003 |
| Full Name | Dr Stephan Charles Boyd Mann |
|---|---|
| Gender | Male |
| Speciality | Preventive Medicine - Preventive Medicine/occupational Environmental Medicine |
| Location | 490l Prospect Blvd, Frederick, Maryland |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1710928551 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2083P0500X | Preventive Medicine - Preventive Medicine/occupational Environmental Medicine | D27170 (Maryland) | Primary |
| Entity Name | Frederick Health Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982600771 PECOS PAC ID: 0446149256 Enrollment ID: O20040311000363 |
News Archive
Forest Laboratories Holdings, Ltd., a wholly owned subsidiary of Forest Laboratories, Inc. and Almirall, S.A. (ALM.MC) today announced that they have entered an agreement to develop, market and distribute LAS100977 in the United States.
Mercury exposure is not associated with an increased risk for hypertension, US research shows.
In a new study published today in JCI Insight, UC Davis researchers have shown that combining high-intensity focused ultrasound with two immunotherapies (a PD-1 checkpoint inhibitor and TLR9 agonist) can produce excellent response rates in mouse models of epithelial cancer.
CEL-SCI Corporation has announced positive results from a long-term follow-up study of head & neck cancer patients treated with its drug Multikine in a Phase II clinical trial.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Stephan Charles Boyd Mann, MD 490l Prospect Blvd, Frederick, MD 21701-6400 Ph: (240) 566-3001 | Dr Stephan Charles Boyd Mann, MD 490l Prospect Blvd, Frederick, MD 21701-6400 Ph: (240) 566-3001 |
News Archive
Forest Laboratories Holdings, Ltd., a wholly owned subsidiary of Forest Laboratories, Inc. and Almirall, S.A. (ALM.MC) today announced that they have entered an agreement to develop, market and distribute LAS100977 in the United States.
Mercury exposure is not associated with an increased risk for hypertension, US research shows.
In a new study published today in JCI Insight, UC Davis researchers have shown that combining high-intensity focused ultrasound with two immunotherapies (a PD-1 checkpoint inhibitor and TLR9 agonist) can produce excellent response rates in mouse models of epithelial cancer.
CEL-SCI Corporation has announced positive results from a long-term follow-up study of head & neck cancer patients treated with its drug Multikine in a Phase II clinical trial.
› Verified 8 days ago
Dr. Qi Chen, M.D., M.P.H. Preventive Medicine Medicare: Medicare Enrolled Practice Location: 490 Prospect Blvd Ste L, Frederick, MD 21701 Phone: 240-566-3001 | |
George Gebus, Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 7158 Oberlin Cir, Frederick, MD 21703 Phone: 301-695-3408 | |
Dr. Anton Nii Adjei Kofi Quist, MD Preventive Medicine Medicare: Medicare Enrolled Practice Location: 1434 Porter St, Frederick, MD 21702 Phone: 301-619-4067 |